✦ LIBER ✦

Hemolytic uremic syndrome after high dose chemotherapy with autologous stem cell support

✍ Scribed by Hans Van Der Lelie; Joke W. Baars; Sjoerd Rodenhuis; Marjan A. Van Dijk; Coby W. De Glas-Vos; Ber L. M. Thomas; Rien H. J. Van Oers; Albert E. G. Kr. Von Dem Borne

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 496 KB
Volume: 76
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19951201)76:11<2338::aid-cncr2820761123>3.0.co;2-p

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose chemotherapy and autologous bl

High dose chemotherapy and autologous blood stem cell support in women with breast carcinoma and isolated supraclavicular lymph node metastases

✍ Rick Abraham; Tracy Nagy; Paul E. Goss; Michael Crump 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## BACKGROUND. The prognosis of patients with isolated supraclavicular lymph node (SCN) metastases is similar to patients with metastatic breast carcinoma involving other sites. Because these patients have a lower disease burden compared with women with distant metastases, their outcome after high

Aerobic exercise in the rehabilitation o

Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation

✍ Fernando C. Dimeo; Monika H. M. Tilmann; Hartmut Bertz; Lothar Kanz; Roland Mert 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 1 views

High-dose chemotherapy with hematopoieti

High-dose chemotherapy with hematopoietic stem-cell support in germ-cell tumor patient treatment: The French experience

✍ A. Fléchon; P. Biron; J.P. Droz 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 105 KB 👁 2 views

## Germ -cell tumors (GCTs) are very chemosensitive and highly curable cancers. For the small proportion of patients who fail conventional chemotherapy (CT), high-dose CT (HDCT) was introduced in France and elsewhere in 1982-1984. We report here on the French experience with HDCT in GCTs. At the C

High dose chemotherapy with autologous s

High dose chemotherapy with autologous stem cell support in the treatment of patients with ovarian carcinoma : Long term results for 105 patients

✍ Takao Shinozuka; Tsuyoshi Miyamoto; Toshinari Muramatsu; Takeshi Hirasawa; Masar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

## BACKGROUND. In this study, the authors reviewed long term results and prognostic factors of high dose chemotherapy (HDC) with autologous stem cell support administered to 105 patients with epithelial ovarian carcinoma. ## METHODS. Prior to HDC, platinum-based chemotherapy was given to optimi

Letter to the editor: Uncertain role of

Letter to the editor: Uncertain role of high dose chemotherapy with autologous stem cell support in pediatric pleuro-pulmonary blastoma (PPB)

✍ Békássy, Albert N.; Garwicz, Stanislaw; Wieve, Thomas; Hägerstrand, Inga 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 17 KB 👁 2 views

## Cell Support in Pediatric Pleuro-Pulmonary Blastoma (PPB) It is worth mentioning that in their otherwise compre-morphological studies of the tumor appearance , which may have some prognostic implications, were hensive review on pleuro-pulmonary blastoma (PPB), Schmaltz et al. [1] made an incor

Prolonged nausea and vomiting after high

Prolonged nausea and vomiting after high dose chemotherapy and autologous peripheral stem cell transplantation in the treatment of high risk breast carcinoma

✍ J. Randolph Hecht; Tony Lembo; Linnea Chap 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

vomiting after high dose chemotherapy with autologous peripheral stem cell transplantation (PSCT) in the treatment of high risk breast carcinoma patients. 1 Division of Digestive Diseases, Department of METHODS. Patients with high risk breast carcinoma were conditioned with high